Introduction
Histamine modulates several physiological functions such as stress-related behaviors, learning, aggressive behaviors, and emotion through its various receptor types [15, 28] . Central histaminergic neurons are located in the tuberomammillary nuclei of the hypothalamus and their neuronal fibers project into the limbic system and neocortex [6] . When histamine is injected into the central amygdala, ventral hippocampus or dorsal hippocampus, it induces an anxiogenic-like response [15, 19, 27] . Several lines of evidence indicate that the destruction of the rat tuberomammillary nucleus (TMN) from which the histaminergic fibers arise can induce anxiolytic-like effects. Meanwhile, the anxiogenic stimuli excite the histaminergic neurons of the TMN which in turn increase the histamine release into target areas such as the hippocampus [6] . In the dorsal hippocampus, histamine can interact with two postsynaptic (H1R and H2R) and one pre-synaptic histamine receptors (H3R) which express in the hippocampal formation [10] . In the dorsal hippocampus, high doses of histamine act on the pre-synaptic H3R which negatively modulates the release of a variety of other neurotransmitters such as acetylcholine and dopamine [4] .
Similar to histamine, dopamine modulates the underlying mechanisms for fear and anxiety [12] . In vitro and in vivo methods have shown that like histaminergic system, the acute exposure to a range of stressors activates the mesocorticolimbic dopaminergic system [1] . Despite some opposite effects exerted by histamine and dopamine, these neurotransmitter systems are shown to similarly increase in response to anxiety-related stress and govern the mechanisms underlying fear and anxiety states. For example, histamine counteracts reward and reinforcement processes mediated by the mesolimbic dopamine system [16] . The action of DA in the brain is mediated by the "D1-like" (D1, D5) and the "D2-like" (D2, D3, D4) receptors [21] . Previous studies have indicated that the D2 dopamine agonist quinpirole, elicits anxiolytic-like response at lower doses, while the higher doses of the drug induce an anxiogenic-like effect [21] . These results have indicated that dopaminergic D2 receptors exert a modulatory action on anxiety.
The dorsal hippocampus receives dopaminergic inputs from the ventral tegmental area (VTA) and histaminergic inputs from TMN [1, 23] . However, the CA1 region of dorsal hippocampus is not considered as the main site for modulation of anxiety and some other hippocampal regions such as the ventral hippocampus, dentate gyrus are also proposed to be critically involved in the modulatory mechanisms for anxiety [29] . Noting the cytoarchitectural dissimilarity between the efferent and afferent connections of the ventral and dorsal hippocampus [25] , there might be a functional heterogeneity between these two regions [8] . For example, our previous studies indicated that histamine have different effects on anxietylike behavior in the dorsal and ventral part of rats' hippocampi [19, 29] .
Given the insights from earlier works, in the present study, the possible involvement of D2 dopaminergic receptors of the dorsal hippocampus in the histamine-induced anxiogenic-like effects has been investigated using the elevated plus maze (EPM) testing method.
Materials and methods

Subjects
Subjects were male NMRI mice weighing 25-30 g bred at the neuroscience lab of the Institute for Cognitive Science Studies (ICSS), Tehran, Iran. Animals were housed 10 per Plexiglas cage, in a room with controlled photoperiod (a12-h light/dark cycle, with light on at 7 a.m.) and the temperature maintained at 22 ± 2 • C. They had food and water available ad lib. and were allowed to adapt to the laboratory conditions for at least 1 week before surgery. All experiments were carried out during the light phase of the cycle. Ten animals were used in each experimental group (a total of 220 mice were used during the experiments). Each animal was used once only. All animal experimentations reported in this study were conducted in accordance with the guidelines laid down by the NIH (NIH Guide for the Care and Use of Laboratory Animals). Given the adherence to the guideline recommendations, the Research and Ethics Committee of the Faculty of Science of the University of Tehran approved the experimental protocol.
Surgery and microinjection
Mice were anesthetized with intra-peritoneal injection of ketamine hydrochloride (50 mg/kg) plus xylazine (5 mg/kg) and placed in a stereotaxic apparatus. The skin was incised and the skull was cleaned. Two 23-gauge guide cannulae were placed 1 mm above the intended site of injection according to the atlas of Paxinos and Franklin [14] . Stereotaxic coordinates for the CA1 region of the dorsal hippocampi were AP: −2 mm from bregma, L: −1.6 from the sagital suture and V: −1.5 mm from the skull surface [14] . The implanted cannulae were secured to anchor jewelers' screws with dental acrylic. Stainless steel stylets (30-gauge) were then inserted into the guide cannulae to keep them free of debris. All animals were allowed 1 week to recover from surgery and to get cleared from the anesthetic effects.
For drug infusion, the animals were gently restrained by hand; the stylets were removed from the guide cannulae and replaced by 30-gauge injection needles (reaching 1 mm below the tip of the guide cannulae). The bilateral intra-CA1 microinjections of drugs, saline or vehicle were at a volume of 1 l (0.5 l/side). Injections were made over a 60-s period, and the injection cannulae were left in place for an additional 60 s to facilitate the diffusion of the drugs. In experiments where the animals received two injections, each mouse received 0.5 l/side (1 l/mouse) of histamine and in 2 min, the 0.5 l/side (1 l/mouse) of a D2 agent was administered.
Behavioral testing (elevated plus-maze)
The elevated plus-maze (EPM) testing has been previously described in great details [26] . Animals were adapted to the testing room for 1 h prior to testing. Our wooden EPM apparatus consisted of two open arms (40 × 7), and two closed arms of the same size surrounded by 10 cm high ends and side walls. The arms were connected by a central 7 cm × 7 cm area. Mice were placed in the center of the plus-maze with their head facing an open arm and left undisturbed for 5 min. Mice were then removed and returned to their home cages. The maze was cleaned with a 10% chlorine bleach solution in between testing sessions. The experimental sessions were digitally recorded and analyzed later. A mouse was considered to be in the central platform when at least two paws were positioned there (i.e. either both front paws or both hind paws and all four paws) and in an arm whenever all four paws were on it. × 100] were used as a measure of anxiety, and the number of total arm entries was taken as a measure for the spontaneous locomotor activity.
Drugs
The administered drugs were histamine dihydrochloride, quinpirole and sulpiride (Sigma, St. Louis, CA, USA). All drugs were dissolved in sterile 0.9% saline just before the experiment, except for sulpiride which was dissolved in one drop of glacial acetic acid with a Hamilton micro-syringe and made up to a volume of 5 ml with sterile 0.9% saline and then diluted to the required volume. Control animals received either saline or vehicle.
2.5. Experimental design 2.5.1. The effects of the intra-dorsal hippocampal administration of histamine on anxiety-like behaviors Four groups of mice received saline (1 l/mouse, intra-CA1) or histamine (2.5, 5 and 10 g/mouse). The testing session was performed 5 min after the drug injection. In all experiments, the %OAT, %OAE and locomotor activity were measured as described earlier in this report.
The effects of quinpirole on histamine-induced anxiogenic response
Eight groups of mice received saline (1 l/mouse, intra-CA1) or histamine (10 g/mouse, intra-CA1), 2 min before the administration of different doses of quinpirole (0, 0.5, 2 and 4 g/mouse, intra-CA1). The testing session was performed 5 min after the final intra-CA1 injection.
The effects of sulpiride on histamine-induced anxiogenic response
Eight groups of mice received saline (1 l/mouse, intra-CA1) or histamine (10 g/mouse, intra-CA1), 2 min before the administration of different doses of sulpiride (0, 0.3, 1 and 3 g/mouse, intra-CA1). The testing session was performed 5 min after the final intra-CA1 injections.
Statistics
Data were expressed as mean ± SEM. Analysis of data was performed using the one-way and two-way analyses of variance (ANOVA). Following a significant F-value, post hoc analysis (LSD test) was performed for specific group comparisons. Differences with P < 0.05 between experimental groups at each point were considered statistically significant.
Verification of cannulae placements
After the testing sessions each mice was deeply anesthetized and 1 l of a 4% methylene-blue solution was infused into the CA1 (1 l/mouse), as described in the drug section. The animals were then decapitated with their brain removed and placed in formaldehyde (10%). After several days, the brains were sliced and the sites of injections were verified according to Paxinos and Franklin [14] . Originally, the cannulae were implanted into the CA1 regions of a total of 220 animals, while only the data from 200 animals with correct cannulae implants were included in the statistical analyses. . The EPM test was performed 5 min after intra-CA1 injections. Each bar represents mean ± S.E.M. %OAT (A), %OAE (B) or locomotor activity (C). ***P < 0.001 when compared to the saline-treated mice.
Results
Effect of intra-CA1 injections of histamine on anxiety-related behaviors
[F(3, 36) = 6.94, P < 0.001] and %OAE [F(3, 36) = 3.48, P < 0.05], whereas did not alter the locomotor activity [F(3, 36) = 0.91, P > 0.05], indicating an anxiogenic-like response elicited by quinpirole ( Fig. 2; left panel) . Moreover, quinpirole (0.5 g/mouse, intra-CA1) reversed the histamine (10 g/mouse) influence on %OAT [F(3, 36) = 11.36, P < 0.001] and %OAE [F(3, 36) = 14.30, P < 0.001]. No significant change in the locomotor activity was observed following the administration of quinpirole plus histamine [F(3,36) = 1.59, P > 0.05]. Based on this, quinpirole appeared to block the histamine-induced anxiogenic-like response ( Fig. 2 ; right panel). Fig. 3 shows the effects of sulpiride in the presence or absence of histamine on anxiety-related behaviors in the EPM. Two-way ANOVA analysis showed a significant interaction between the effects of histamine (Factor A) and those induced by sulpiride (Factor B) on the %OAT [Factor A; F(1,72) = 10.14, P < 0.001, Factor B; F(3,72) = 3.66, P < 0.05, Factor (A × B); F(3,72) = 22.07, P < 0.001], %OAE [Factor A; F(1,72) = 25.10, P < 0.001, Factor B; Fig. 2 . The effects of intra-CA1 injection of quinpirole on histamine-induced anxiogenic response. Mice were injected with saline (1 l/mouse) or histamine (10 g/mouse, intra-CA1) 2 min before injection of different doses of quinpirole (1, 3 and 6 g/mouse). The EPM tests were performed 5 min after the final intra-CA1 injection. Each bar represents mean ± S.E.M. %OAT (A), %OAE (B) or locomotor activity (C). *P < 0.05, **P < 0.01 as compared to the saline/saline treated mice. « « « P < 0.001 as compared to histamine/saline group. ## P < 0.01 and ### P < 0.001, as compared to respective control group. Fig. 3; right panel) . Fig. 3 . The effects of intra-CA1 injection of sulpiride on histamine-induced anxiogenic response. Mice were injected with vehicle (1 l/mouse) or histamine (10 g/mouse, intra-CA1) 2 min before injection of different doses of sulpiride (0.3, 1 and 3 g/mouse). The EPM tests were performed 5 min after the final intra-CA1 injections. Each bar represents mean ± S.E.M. %OAT (A), %OAE (B) or locomotor activity (C). ***P < 0.001 as compared to the saline/saline treated mice. « « P < 0.01 as compared to histamine/saline group. # P < 0.05, ## P < 0.01 and ### P < 0.001, as compared to respective control group.
Effects of intra-CA1 injections of sulpiride in the presence or absence of histamine on anxiety-related behaviors
Discussion
In the present study, the effects of histamine and DA D2 receptor agents on anxiety-related behaviors, as well as their interactions in the dorsal hippocampus of mice have been investigated.
The effects of histamine on anxiety-like behavior in the dorsal hippocampus
Our present results showed that intra-CA1 injection of histamine reduces the %OAT and %OAE, but not the locomotor activity in EPM. This possibly translates to the anxiogenic-like response elicited by histamine. Previously, we showed that histamine injection into the dorsal hippocampus of mice induced anxiety in the hole board test [28] . We have also shown that the administration of histamine into rats' central amygdala [27] , ventral hippocampus [19] as well as mice 's dorsal hippocampus [15] induced anxietylike behavior in the EPM, whereas histamine administration into rats' dorsal hippocampi showed anxiolytic-like effects in the EPM test [29] . Our data may be supported by the previous findings in which activation of histamine H1 receptors could induce anxiety in the light/dark box test [11] . Moreover, it has been shown that anxiety can be induced by the co-administration of a neuronal histamine releaser, thioperamide, with a histamine agonist, betahistine [9] . On the contrary, it has been reported that intraventral hippocampal administration of histamine in rats decreased the fear-like behaviors in the elevated asymmetric plus-maze [20] . Furthermore, injection of histamine into the nucleus accumbens of rats produced a dual effect in asymmetric plus-maze [13] . Taken together, the here with presented data suggested that histamine may have different effects on anxiety-like behaviors, being either anxiogenic/anxiolytic or even without specific effect, depending on the site of injection, species, strain, doses, and the methods of testing. Histamine release has been proposed to be a sensitive indicator of stress and its turnover in the brain is shown to be increased in response to stress. On the other hand, lesions of the TMN would induce anxiolytic response [6] . The exact mechanism by which histamine induces anxiety has not been completely understood. The effects of histamine could be due to the decrease in acetylcholine release and/or other neurotransmitters through presynaptic H3R. Thus, the hippocampal cholinergic and dopaminergic systems have also been proposed to be involved in the modulation of anxiety-like behaviors [2] .
The effects of intra-dorsal hippocampal administration of dopaminergic D2 receptor agents on anxiety-like behaviors
Our further experiments revealed the effect of bilateral intra-CA1 injection of dopaminergic D2 receptor agents on anxiety-like behaviors. Results indicated that the intra-CA1 microinjection of quinpirole, D2 receptor agonist and sulpiride, D2 receptor antagonist decreases the %OAT and %OAE, but not the locomotor activity in EPM, indicating anxiety-like behavior in mice. This is in agreement with other investigators showing that the D2 receptor antagonists could influence anxiety like behaviors [17] . Under normal conditions, this may indicate that the dorsal hippocampal dopaminergic system exerts physiological influence on anxiety-like behaviors. The role of D2 receptors in anxiety-like behaviors is however less clear. The systemic administration of sulpiride [17] is shown to elicit anxiogenic effects in the white and black Box test [22] , the Light-Induced Switch off paradigm [17] and two non-conditioned tests of anxiety [18] , while intra-amygdala D2-dopamine receptor antagonists injections induced anxiolytic effects in conditioned models of anxiety [7] . Dopamine D1 receptors were found to be mainly post-synaptic, whereas dopamine D2 receptors are localized both pre-synaptically and post-synaptically [3] . Therefore, the effect of quinpirole and sulpiride may be mediated either through pre-or post-synaptic D2 receptors site. Our findings substantiated that the administration of a higher dose of sulpiride induced anxiety. The antagonist may block pre-synaptic dopamine autoreceptors, releases dopamine which in turn may influence anxiety-like behaviors by acting on postsynaptic dopamine receptors. In support of this idea, Simon et al. showed that the dopamine agonists GBR12783 and RU24926 both produced an anxiogenic response in mice [22] . Interestingly, there are some reports indicating that the stress-induced increase in dopamine metabolism can be attenuated by anxiolytic drugs such as diazepam [5] . This finding supports the contention that dopamine activation is central to the expression of anxiety. Our data also showed that administration of quinpirole induced anxiety. The possible explanation for our results is that quinpirole mimics the effect of dopamine by post-synaptic D2 receptors activation. An interesting finding in our experiment is that when dopamine transmission is augmented either by autoreceptor blockade or postsynaptic DA receptor agonists, it may induce anxiety-like behaviors.
The effects of dopaminergic agents upon anxiogenic-like behaviors induced by dorsal hippocampal histamine administration
While quinpirole and sulpiride by themselves exert an anxiogenic effect in the dorsal hippocampus, these drugs in together with histamine showed anxiolytic response in EPM test. Dopaminergic agents have a central role in reward mechanisms [24] . There are reports indicating that central histamine counteracts reward and reinforcement processes mediated by the mesolimbic dopamine system [16] . Evidence has indicated that the dorsal hippocampus histamine negatively modulates the release of dopamine and other neurotransmitters such as acetylcholine via H3 heteroceptors activation [4] . H3 receptor activation through intra-CA1 injection of histamine decreases the dopamine release [3] , whereas quinpirole and sulpiride result in the potentiated dopamine transmission through postsynaptic DA receptor activation and autoreceptor blockade, respectively [22] . Given the above, these drugs may block the histamine-induced anxiety-like behaviors through such mechanisms.
